Carnegie Investment Counsel’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.06M | Hold |
1,975
| – | – | 0.02% | 300 |
|
|
2025
Q1 | $814K | Buy |
+1,975
| New | +$814K | 0.02% | 309 |
|
|
2024
Q4 | – | Sell |
-405
| Closed | -$205K | – | 471 |
|
|
2024
Q3 | $205K | Buy |
+405
| New | +$205K | 0.01% | 454 |
|
|
2024
Q2 | – | Sell |
-400
| Closed | -$216K | – | 483 |
|
|
2024
Q1 | $216K | Sell |
400
-1
| -0.2% | -$540 | 0.01% | 468 |
|
|
2023
Q4 | $223K | Buy |
+401
| New | +$223K | 0.01% | 458 |
|
|
2023
Q3 | – | Sell |
-401
| Closed | -$201K | – | 491 |
|
|
2023
Q2 | $201K | Sell |
401
-175
| -30% | -$87.9K | 0.01% | 481 |
|
|
2023
Q1 | $288K | Sell |
576
-1
| -0.2% | -$500 | 0.01% | 441 |
|
|
2022
Q4 | $235K | Buy |
+577
| New | +$235K | 0.01% | 459 |
|
|
2022
Q3 | – | Sell |
-597
| Closed | -$209K | – | 486 |
|
|
2022
Q2 | $209K | Sell |
597
-419
| -41% | -$147K | 0.01% | 448 |
|
|
2022
Q1 | $556K | Buy |
1,016
+124
| +14% | +$67.9K | 0.02% | 331 |
|
|
2021
Q4 | $587K | Sell |
892
-103
| -10% | -$67.8K | 0.02% | 336 |
|
|
2021
Q3 | $619K | Hold |
995
| – | – | 0.02% | 292 |
|
|
2021
Q2 | $628K | Buy |
995
+20
| +2% | +$12.6K | 0.02% | 298 |
|
|
2021
Q1 | $477K | Buy |
975
+275
| +39% | +$135K | 0.02% | 323 |
|
|
2020
Q4 | $350K | Hold |
700
| – | – | 0.02% | 340 |
|
|
2020
Q3 | $275K | Hold |
700
| – | – | 0.01% | 354 |
|
|
2020
Q2 | $231K | Buy |
+700
| New | +$231K | 0.01% | 375 |
|